A service of the U.S. National Library of Medicine
National Institutes of Health
National Institutes of Health 
U.S. Plans Billion-Dollar Project to Study the Brain
Hope is the initiative will lead to breakthroughs for diseases like Alzheimer's, Parkinson's
Monday, February 18, 2013
MONDAY, Feb. 18 (HealthDay News) -- An unprecedented, 10-year study of the human brain is expected to be unveiled by the Obama administration as early as next month, The New York Times reported Monday.
President Barack Obama cited the need for brain research in his State of the Union address last week, and the Times reported Monday that scientists, government agencies and private foundations expect to team up in an effort to reveal the mysterious inner workings of the brain's chemistry.
The project is known as the Brain Activity Map project, the news report said, and the ultimate goal is to create a detailed map of the brain, which is composed of billions of neurons, and to better understand mental illnesses and brain disorders such as Alzheimer's, Parkinson's and autism.
The U.S. National Institutes of Health-sponsored research might even lead to breakthroughs in artificial intelligence, the newspaper reported.
Experts welcomed the news.
"This initiative has the potential to revolutionize our understanding of neural circuits, providing the fundamental knowledge that is critical for developing treatments for a host of neurological and psychiatric disorders," said Dr. David Fitzpatrick, scientific director and chief executive officer of the Max Planck Florida Institute for Neuroscience.
Dr. Ashesh Mehta, head of the Laboratory of Multimodal Brain Mapping at the Feinstein Institute for Medical Research in Manhasset, N.Y., agreed.
He said the advent of new brain-mapping technologies has brought "an explosion of information in recent years, and the need to coordinate and synthesize this information from the single neuron to the whole brain is upon us now.
"This would not only pave the path toward treating neurological and psychiatric disorders such as Alzheimer's disease, autism, depression and paralysis," Mehta added, "but it will also help us develop better technology."
Scientists hope that the effort will have the same wide-reaching effect on brain research and knowledge that the Human Genome Project had on genetics. When it was completed in 2003, the 13-year Human Genome Project had mapped all of the genes in human DNA. The project cost $3.8 billion, but had returned $800 billion by 2010, the Times said.
George Church, a molecular biologist at Harvard University involved with both projects, said of the brain mapping project: "We probably won't spend less money, but we will probably get a lot more bang for the buck."
Scientists discussing the brain project said they hope Congress would allot $3 billion or more over the length of the initiative, the newspaper said.
One Alzheimer's specialist voiced enthusiasm for the project.
"Unbiased approaches such as this and such as the Human Genome Project are most useful in revealing 'unknown unknowns' -- information that we would never learn through standard logic and hypothesis-testing because these connections would never cross our minds," said Dr. Sam Gandy, associate director at the Mount Sinai Alzheimer's Disease Research Center in New York City.
SOURCES: Sam Gandy, M.D., associate director, Mount Sinai Alzheimer's Disease Research Center, New York City; Ashesh Mehta, MD, head of the Laboratory of Multimodal Brain Mapping, Feinstein Institute for Medical Research, Manhasset, NY; David Fitzpatrick, M.D., scientific director and chief executive officer, Max Planck Florida Institute for Neuroscience, Jupiter, Fla.; The New York TimesPresident Barack Obama cited the need for brain research in his State of the Union address last week, and the Times reported Monday that scientists, government agencies and private foundations expect to team up in an effort to reveal the mysterious inner workings of the brain's chemistry.
The project is known as the Brain Activity Map project, the news report said, and the ultimate goal is to create a detailed map of the brain, which is composed of billions of neurons, and to better understand mental illnesses and brain disorders such as Alzheimer's, Parkinson's and autism.
The U.S. National Institutes of Health-sponsored research might even lead to breakthroughs in artificial intelligence, the newspaper reported.
Experts welcomed the news.
"This initiative has the potential to revolutionize our understanding of neural circuits, providing the fundamental knowledge that is critical for developing treatments for a host of neurological and psychiatric disorders," said Dr. David Fitzpatrick, scientific director and chief executive officer of the Max Planck Florida Institute for Neuroscience.
Dr. Ashesh Mehta, head of the Laboratory of Multimodal Brain Mapping at the Feinstein Institute for Medical Research in Manhasset, N.Y., agreed.
He said the advent of new brain-mapping technologies has brought "an explosion of information in recent years, and the need to coordinate and synthesize this information from the single neuron to the whole brain is upon us now.
"This would not only pave the path toward treating neurological and psychiatric disorders such as Alzheimer's disease, autism, depression and paralysis," Mehta added, "but it will also help us develop better technology."
Scientists hope that the effort will have the same wide-reaching effect on brain research and knowledge that the Human Genome Project had on genetics. When it was completed in 2003, the 13-year Human Genome Project had mapped all of the genes in human DNA. The project cost $3.8 billion, but had returned $800 billion by 2010, the Times said.
George Church, a molecular biologist at Harvard University involved with both projects, said of the brain mapping project: "We probably won't spend less money, but we will probably get a lot more bang for the buck."
Scientists discussing the brain project said they hope Congress would allot $3 billion or more over the length of the initiative, the newspaper said.
One Alzheimer's specialist voiced enthusiasm for the project.
"Unbiased approaches such as this and such as the Human Genome Project are most useful in revealing 'unknown unknowns' -- information that we would never learn through standard logic and hypothesis-testing because these connections would never cross our minds," said Dr. Sam Gandy, associate director at the Mount Sinai Alzheimer's Disease Research Center in New York City.
HealthDay
Health News Copyright (c) 2013 HealthDay. All rights reserved.
- More Health News on:
- Brain Diseases
- Mental Disorders
.png)
No hay comentarios:
Publicar un comentario